APA (7th ed.) Citation

(2017). Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes.

Chicago Style (17th ed.) Citation

Lixisenatide Reduces Glycaemic Variability in Insulin-treated Patients with Type 2 Diabetes. 2017.

MLA (8th ed.) Citation

Lixisenatide Reduces Glycaemic Variability in Insulin-treated Patients with Type 2 Diabetes. 2017.

Warning: These citations may not always be 100% accurate.